Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (MFR control number GB-1577272925-2016002945) ON 01-APR-2016. This case was received from RA (Ref No. GB-MHRA-EYC 00135594, GB-MHRA-ADR 23363271) on 29-MAR-2016. Initial case received from a consumer/other non-health professional concerns a 13-year-old female adolescent patient received GARDASIL (Lot number J014252, expiry date: 31-JUL-2016) via parenteral route on 24-SEP-2014, GARDASIL (batch number K006781) via parenteral route on 23-APR-2015. The patient experienced "Dizziness and nausea" on 24-NOV-2014, "Various, numerous including abdominal pains so severe, appendix removed", several visits to hospital A&E on 05-MAR-2015, "Pain in legs, arms neck, chest, Orthostatic hypertension, fatigue" on 01-FEB-2016. The reporter stated that they had many trips to doctors over the year, including 3 trips to Accident and Emergency, an unnecessary operation, visits to specialists Respiratory and Cardiologists. The patient had a medical history of Appendectomy. Additional investigations included: Blood Test repeated several times, all negative on an unknown date, Ultrasound Scan negative on an unknown date. The patient''s outcome was reported as Not Recovered/Not Resolved.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166